Analyst: This Drug Stock Could Double

H.C. Wainwright started coverage of UROV shares with a "buy" rating

Mar 11, 2019 at 1:50 PM
facebook twitter linkedin


The shares of Urovant Sciences Ltd (NASDAQ:UROV) are up 1.9% to trade at $13.30 today, after analysts at H.C. Wainwright launched coverage with a "buy" rating. What's more, the brokerage firm set a Street-high price target of $28 for UROV, representing more than double the equity's current price -- and twice its initial public offering (IPO) price of $14. The analyst waxed optimistic on Urovant Sciences' lead product, vibegron, which treats overactive bladder -- a condition that is increasing in step with the aging U.S. population.

UROV stock went public in late September, and peaked at $14.32 on Oct. 4. The equity subsequently plummeted to a record low of $4.05 by Dec. 21, before erasing almost all of that deficit in 2019. The Wall Street freshman hasn't closed a day above that key $14 IPO price ever, though.

UROV stock chart march 11

Although UROV has been trading just a few months, it's no stranger to upbeat analyst attention. All four brokerage firms following the shares deem it worthy of a "buy" or better rating, and the consensus 12-month price target of $24 represents expected upside of 80.5% to the security's current perch.

In conclusion, traders should keep an eye on Urovant stock's dance around the key $14 level, as a close above its IPO price could mark a psychological hurdle for investors. Meanwhile, it should be noted that UROV's lock-up period expires on March 25.

 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners